Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-08-02
2011-08-02
Chernyshev, Olga N (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388150, C530S387100, C424S130100, C424S141100, C424S142100, C424S146100
Reexamination Certificate
active
07989597
ABSTRACT:
This application pertains to antibodies which specifically bind to immunogenic memapsin 2β-secretase peptides for use in the treatment of Alzheimer's disease and memapsin 2β-secretase disorders. The application also pertains to immunogenic compositions comprising memapsin 2β-secretase peptides and uses thereof.
REFERENCES:
patent: 6545127 (2003-04-01), Tang et al.
patent: 6790610 (2004-09-01), Gurney et al.
patent: WO 2007/021886 (2007-02-01), None
patent: WO 2009/121948 (2009-10-01), None
Capell et al., “Maturation and pro-peptide cleavage of beta-secretase,”J. Biol. Chem.,275:30849-30854, 2000.
Chang et al., “Amyloid-beta reduction by memapsin 2 (beta-secretase) immunization,”FASEB J.,21:3184-3196, 2007.
Chang et al., “P2-323: Memapsin 2 (beta-secretase, BACE) immunization as specific and safe therapy for Alzheimer's disease,”Alzheimer's&Dementia: Journal of the Alzheimer's Association,4: T467, 2008.
Ermolieff et al., “Proteolytic activation of recombinant pro-memapsin 2 (pro-beta-secretase) studied with new fluorogenic substrates,”Biochemistry,39:12450-12456, 2000.
Harada et al., “Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains,”Neuroscience Research,54:24-29, 2006.
He et al., “Memapsin 2 (beta-secretase) cytosolic domain binds to the VHS domains of GGA1 and GGA2: implications on the endocytosis mechanism of memapsin 2,”FEBS Lett.,524:183-187, 2002.
Hong et al., “Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor,”Science,290:150-153, 2000.
Hussain et al., “Identification of a novel aspartic protease (Asp 2) as beta-secretase,”Mol. Cell. Neurosci.,14:419-427, 1999.
International Search Report and Written Opinion, issued in Application No. PCT/US2009/048176, date of mailing Nov. 12, 2009.
Lin et al., “Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein,”Proc. Natl. Acad. Sci. U.S.A.,97:1456-1460, 2000.
Oddo et al., “Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology,”J. Biol. Chem.,281:1599-1604, 2006.
Sinha et al., “Purification and cloning of amyloid precursor β-secretase from human brain,”Nature,402:537-540, 1999.
Turner et al., “Subsite specificity of memapsin 2 (beta-secretase): implications for inhibitor design,”Biochemistry,40:10001-10006, 2001.
Vassar et al., “Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE,”Science,286:735-741, 1999.
Yan et al., “Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity,”Nature,402:533-537, 1999.
Zhao et al., “β-site amyloid precursor protein cleaving enzyme I levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis,”J. Neurosci.,27:3639-49, 2007.
Chang Wan-Pin
Tang Jordan
Chernyshev Olga N
Fulbright & Jaworski
Oklahoma Medical Research Foundation
LandOfFree
Immunogenic memapsin 2 β-secretase peptides and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic memapsin 2 β-secretase peptides and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic memapsin 2 β-secretase peptides and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2754090